Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study

Current views on lupus in children

(2022) Eve M.D. Smith et al.   CURRENT OPINION IN RHEUMATOLOGY

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

(2022) Alexandre Sepriano et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort

(2021) Sujata Sawhney et al.   LUPUS

An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus

(2021) Vitor Cavalcanti Trindade et al.   PEDIATRIC DRUGS

International Consensus For The Dosing Of Corticosteroids In Childhood‐Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis

(2021) Nathalie E. Chalhoub et al.   Arthritis & Rheumatology

Update on Lupus Nephritis: Core Curriculum 2020

(2020) Samir V. Parikh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

(2020) Hermine I Brunner et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab use as induction therapy for lupus nephritis: a systematic review

(2020) Liya Stolyar et al.   LUPUS

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents

(2020) Leanna M. Wise et al.   Frontiers in Medicine

Update οn the diagnosis and management of systemic lupus erythematosus

(2020) Antonis Fanouriakis et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs

(2020) Guillermo Ruiz-Irastorza et al.   RHEUMATOLOGY

Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis

(2017) Biswanath Basu et al.   PEDIATRIC NEPHROLOGY

Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus

(2016) J S Hui-Yuen et al.   LUPUS

Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases

(2015) A. Tambralli et al.   JOURNAL OF RHEUMATOLOGY

The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE

(2014) L Watson et al.   LUPUS

Rituximab treatment in lupus nephritis – where do we stand?

(2013) I Gunnarsson et al.   LUPUS

Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis

(2013) RJ Davies et al.   LUPUS

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM